Cassava Sciences Inc vs Lucid Group Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Lucid Group Inc trades at $6.7 (market cap $2.64B). The key difference: Lucid Group Inc is far larger — about 55.3× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.
| FLNA | LCID | |
|---|---|---|
Market Cap | $47.75M | $2.64B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $24.77 |
52-Week Low | $0.87 | $4.62 |
Enterprise Value | -$34.93M | $5.54B |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →